Considering the tumour heterogeneity between melanoma and GC, together with our results, it is reasonable to speculate that MAPK1 promotes GC proliferative/metastatic properties via phosphorylation of MITF (Serine73), enhancing its activity instead of stability. The gene discussed is MAPK1; the disease is melanoma.